Unison Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,283
| Closed | -$727K | – | 199 |
|
|
2024
Q2 | $727K | Hold |
2,283
| – | – | 0.09% | 116 |
|
|
2024
Q1 | $524K | Hold |
2,283
| – | – | 0.05% | 145 |
|
|
2023
Q4 | $502K | Hold |
2,283
| – | – | 0.05% | 146 |
|
|
2023
Q3 | $516K | Hold |
2,283
| – | – | 0.06% | 134 |
|
|
2023
Q2 | $504K | Hold |
2,283
| – | – | 0.06% | 138 |
|
|
2023
Q1 | $511K | Hold |
2,283
| – | – | 0.06% | 130 |
|
|
2022
Q4 | $635K | Hold |
2,283
| – | – | 0.08% | 108 |
|
|
2022
Q3 | $478K | Buy |
2,283
+530
| +30% | +$111K | 0.09% | 118 |
|
|
2022
Q2 | $413K | Hold |
1,753
| – | – | 0.11% | 110 |
|
|
2022
Q1 | $314K | Hold |
1,753
| – | – | 0.08% | 154 |
|
|
2021
Q4 | $379K | Hold |
1,753
| – | – | 0.09% | 138 |
|
|
2021
Q3 | $324K | Hold |
1,753
| – | – | 0.08% | 150 |
|
|
2021
Q2 | $314K | Hold |
1,753
| – | – | 0.06% | 154 |
|
|
2021
Q1 | $293K | Hold |
1,753
| – | – | 0.06% | 167 |
|
|
2020
Q4 | $266K | Buy |
+1,753
| New | +$266K | 0.06% | 163 |
|
|
2020
Q3 | – | Sell |
-1,753
| Closed | -$212K | – | 164 |
|
|
2020
Q2 | $212K | Buy |
+1,753
| New | +$212K | 0.07% | 125 |
|
|
2019
Q2 | – | Sell |
-1,753
| Closed | -$205K | – | 165 |
|
|
2019
Q1 | $205K | Buy |
+1,753
| New | +$205K | 0.15% | 148 |
|
|
2018
Q4 | – | Sell |
-1,753
| Closed | -$224K | – | 178 |
|
|
2018
Q3 | $224K | Buy |
+1,753
| New | +$224K | 0.16% | 155 |
|
|
2018
Q1 | – | Sell |
-1,753
| Closed | -$259K | – | 155 |
|
|
2017
Q4 | $259K | Buy |
+1,753
| New | +$259K | 0.19% | 124 |
|